| Nov 14 |
Investors Can Find Comfort In McKesson's (NYSE:MCK) Earnings Quality
|
| Nov 13 |
McKesson Stock Gets A RS Rating Lift To 75
|
| Nov 13 |
McKesson, Cencora slapped with $266M in damages in Baltimore opioid lawsuit
|
| Nov 13 |
All You Need to Know About McKesson (MCK) Rating Upgrade to Buy
|
| Nov 13 |
Baltimore wins $266 million in opioid case against distributors
|
| Nov 13 |
Are Investors Undervaluing Cardinal Health (CAH) Right Now?
|
| Nov 13 |
McKesson (MCK) Is Considered a Good Investment by Brokers: Is That True?
|
| Nov 12 |
McKesson Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
|
| Nov 11 |
Here is Why Growth Investors Should Buy McKesson (MCK) Now
|
| Nov 11 |
5 Stocks That Look Promising Following Broker Rating Upgrades
|
